SCHEMBL2382891

SCHEMBL2382891

COc1ccc2c(c1)c1cc(-c3cc(F)cc(F)c3)c(=O)n(C)c1n2C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ APAF1 O14727 1/20 0.46
▸ PABPC1 P11940 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ IDO1 P14902 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ MCL1 Q07820 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ BCHE P06276 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2385267 0.84 KDM4E (0.43) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL2384414 0.79 PADI4 (0.44) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL2385324 0.76 ALDH1A1 (0.47) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL3867031 0.76 KDM4E (0.51) ALDH1A1MAPTNPSR1KDM4EHPGD
SCHEMBL4775814 0.73 ALDH1A1 (0.44) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL3445477 0.72 KDM4E (0.40) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL15264375 0.72 BRD4 (0.58) TXNRD1TXNRD3TXNRD2KCNA5KCNH2
SCHEMBL2385054 0.71 MAPT (0.46) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL2381071 0.71 KDM4E (0.44) ALDH1A1MAPTNPSR1MAPK1APAF1
SCHEMBL1336997 0.70 MAPK14 (0.49) ALDH1A1MAPTNPSR1IDO1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012991-B2 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent; amidating a 2-aminoindole with an alpha-substituted-beta-hydroxy-alkyl acrylate SANOFI-AVENTIS (FR) 2011-09-06 — — US disclosed
US-20080214538-A1 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics SANOFI-AVENTIS (FR) 2008-09-04 — — US disclosed
US-7390818-B2 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2008-06-24 — — US disclosed
US-20050288318-A1 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288318-A1 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics PNPO, PDXK, PLPBP ALDH1A1 563/4885MAPT 1995/4885NPSR1 2214/4885
US-20080214538-A1 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics PNPO, PLPBP, DPYD ALDH1A1 776/4885MAPT 2131/4885NPSR1 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback